Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 4/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CA7 | P43166 | 2/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14694703 | 1.00 | LMNA (0.46) | LMNAKDM4CMEN1KMT2ACYP1A2 | |
| SCHEMBL12519153 | 0.89 | KDM4C (0.43) | LMNAKDM4CMEN1KMT2ACYP1A2 | |
| SCHEMBL14695067 | 0.89 | KDM4C (0.43) | LMNAKDM4CMEN1KMT2ACYP1A2 | |
| SCHEMBL14695139 | 0.89 | KDM4C (0.48) | LMNAKDM4CMEN1KMT2ACYP1A2 | |
| SCHEMBL12519369 | 0.89 | KDM4C (0.48) | LMNAKDM4CMEN1KMT2ACYP1A2 | |
| SCHEMBL12519341 | 0.88 | MMP3 (0.39) | LMNAKDM4CMEN1KMT2ACYP1A2 | |
| SCHEMBL14695908 | 0.88 | MMP3 (0.39) | LMNAKDM4CMEN1KMT2ACYP1A2 | |
| SCHEMBL14695286 | 0.86 | KDM4C (0.41) | LMNAKDM4CMEN1KMT2ACYP1A2 | |
| SCHEMBL12519391 | 0.86 | KDM4C (0.41) | LMNAKDM4CMEN1KMT2ACYP1A2 | |
| SCHEMBL2761543 | 0.83 | MEN1 (0.64) | LMNAKDM4CMEN1KMT2ACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130046013-A1 | SALICYLATE FATTY ACID DERIVATIVES | HOVLAND RAGNAR (NO) | 2013-02-21 | — | — | US | disclosed |
| US-20130046013-A1 | SALICYLATE FATTY ACID DERIVATIVES | HOVLAND RAGNAR (NO) | 2013-02-21 | — | — | US | disclosed |
| US-20130046013-A1 | SALICYLATE FATTY ACID DERIVATIVES | HOVLAND RAGNAR (NO) | 2013-02-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130046013-A1 | SALICYLATE FATTY ACID DERIVATIVES | FASN, SCD, FABP2 | LMNA 2520/4885KDM4C 4019/4885MEN1 4781/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.